Donnelly Centre researchers have uncovered a genetic network linked to autism. The findings, described in the journal Molecular Cell, will facilitate developing new therapies for this common neurological disorder.
As part of a collaborative research program focusing on autism led by Benjamin Blencowe, a professor in the University of Toronto’s Donnelly Centre for Cellular and Biomolecular Research, postdoctoral fellow Thomas Gonatopoulos-Pournatzis, lead author of the study, uncovered a network of more than 200 genes involved in controlling alternative splicing events that are often disrupted in autism spectrum disorder (ASD). Alternative splicing is a process that functionally diversifies protein molecules—cells’ building blocks—in the brain and other parts of the body. Blencowe’s laboratory previously showed that disruption of this process is closely linked to altered brain wiring and behaviour found in autism.
“Our study has revealed a mechanism underlying the splicing of very short coding segments found in genes with genetic links to autism,” says Blencowe, who is also a professor in the Department of Molecular Genetics and holds the Banbury Chair of Medical Research at U of T. “This new knowledge is providing insight into possible ways of targeting this mechanism for therapeutic applications”.
Best known for its effects on social behaviour, autism is thought to be caused by mishaps in brain wiring laid down during embryo development. Hundreds of genes have been linked to autism, making its genetic basis difficult to untangle. Alternative splicing of small gene fragments, or microexons, has emerged as a rare, unifying concept in the molecular basis of autism after Blencowe’s team previously discovered that microexons are disrupted in a large proportion of autistic patients.
As tiny protein-coding gene segments, microexons impact the ability of proteins to interact with each other during the formation of neural circuits. Microexons are especially critical in the brain, where they are included into the RNA template for protein synthesis during the splicing process. Splicing enables the utilization of different combinations of protein-coding segments, or exons, as a way of boosting the functional repertoires of protein variants in cells.
And while scientists have a good grasp of how exons, which are about 150 DNA letters long, are spliced, it remained unclear how the much-smaller microexons— a mere 3-27 DNA letters long—are utilized in nerve cells.
“The small size of microexons’ presents a challenge for the splicing machinery and it has been a puzzle for many years how these tiny exons are recognized and spliced,” says Blencowe.
To answer this question, Gonatopoulos-Pournatzis developed a method for identifying genes that are involved in microexon splicing. Using the powerful gene editing tool CRISPR, and working with Mingkun Wu and Ulrich Braunschweig in the Blencowe lab as well as with Jason Moffat’s lab in the Donnelly Centre, Gonatopoulos-Pournatzis removed from cultured brain cells each of the 20,000 genes in the genome to find out which ones are required for microexon splicing. He identified 233 genes whose diverse roles suggest that microexons are regulated by a wide network of cellular components.
“A really important advantage of this screen is that we’ve been able to capture genes that affect microexon splicing both directly and indirectly and learn how various molecular pathways impinge on this process,” says Blencowe.
Furthermore, Gonatopoulos-Pournatzis was able to find other factors that work closely with a previously identified master regulator of microexon splicing, a protein called nSR100/SRRM4, discovered previously in the Blencowe lab. Working with Anne-Claude Gingras’ team at Sinai Health System’s Lunenfeld-Tanenbaum Research Institute, they identified proteins called Srsf11 and Rnps1 as forming a molecular complex with nSR100.
Knowing the precise molecular mechanisms of microexon splicing will help guide future efforts to develop potential therapeutics for autism and other disorders. For example, because the splicing of microexons is disrupted in autism, researchers could look for drugs capable of restoring their levels to those seen in unaffected individuals.
“We now better understand the mechanism of how the microexons are recognized and spliced specifically in the brain,” says Gonatopoulos-Pournatzis, who recently won the Donnelly Centre’s newly established Research Excellence Award . “When you know the mechanism, you can potentially target it using rational approaches to develop therapies for neurodevelopmental disorders.”
Learn more: Unraveling a Genetic Network Linked to Autism
The Latest on: Autism
via Google News
The Latest on: Autism
- Support Group for Men with Autismon March 22, 2020 at 8:21 am
Support Group for Men with Autism - Support Group hosted by Dr. Dr. Jenifer Balch, PhD, LPC-S, RPT-S, CAS in Dallas, TX, 75230, (972) 441-7593, This processing group is designed for adult males on the ...
- 6 Sensory-Friendly Home Activities For Kids On The Autism Spectrumon March 21, 2020 at 5:30 am
Many school children on the autism spectrum have a lot of free time on their hands, now we are under enhanced community quarantine. Therapy schedules may also be disrupted, leaving many parents ...
- Autism rates declining among wealthy whites, escalating among pooron March 20, 2020 at 5:13 am
Wealthy, white California counties—once considered the nation's hotbeds for autism spectrum disorder (ASD) - have seen prevalence flatten or fall in the last two decades, while rates among poor whites ...
- Men on the Autism Spectrumon March 19, 2020 at 3:43 pm
This group is for adult men on the autism spectrum who can independently participate in a group therapy setting. The group provides psychoeducation about autism, discussing of coping skills and social ...
- Can AI Help With Autism Diagnosis?on March 19, 2020 at 10:52 am
An Interview with Cognoa’s CEO Brent Vaughan In the US, one in five children are living with a diagnosable behavioral health disorder; however, only 21% of those children who are diagnosed receive ...
- Multi-modular AI Approach to Streamline Autism Diagnosis in Young Childrenon March 19, 2020 at 3:21 am
Autism has become a pressing healthcare challenge. The instruments used to aid diagnosis are time and labor expensive and require trained clinicians to administer, leading to long wait times for ...
- Identifying predictive features of autism spectrum disorders in a clinical sample of adolescents and adults using machine learningon March 18, 2020 at 3:10 am
Diagnosing autism spectrum disorders (ASD) is a complicated, time-consuming process which is particularly challenging in older individuals. One of the most widely used behavioral diagnostic tools is ...
- Autism Family Network makes changes to annual Capital City Blue Runon March 17, 2020 at 10:01 am
The Autism Family Network has changed its annual Capital City Blue Run to a virtual event due to coronavirus concerns.
- New Strategy Can Aid Parenting Kids with Autismon March 17, 2020 at 5:18 am
Parenting a child with autism spectrum disorder is a challenging endeavor. New research suggests an updated parenting strategy can help a child receive reinforcement and guidance and ease the time ...
via Bing News